Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Pharmaceutical Industries Ltd.
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Q1 results in focus with eye on revenue numbers | Seeking Alpha
Teva Announces Results from Exploratory 52-Week Phase 2 PRIDE-HD Study of Pridopidine in Huntington Disease - Huntington's Disease News
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva Pharmaceutical loses another CEO, leaving investors to guess what's next | Mint
Can Teva Pharmaceutical's Q4 results bring positive surprise? | Seeking Alpha
Articles about Teva Pharmaceuticals
New York court dismisses most of Teva claims against Mexican drugmakers | The Times of Israel
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Questions that global generic behemoth Teva's results raise for Indian pharma - BusinessToday
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Performance Analysis - Simply Wall St
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
